Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
12/2000
12/28/2000WO2000078323A1 A use of icariin in preparing the medicine for preventing and treating sexual disorder and vasoconstrictive diseases
12/28/2000WO2000078320A1 Cartilage enhancing food supplements and methods of preparing the same
12/28/2000WO2000078319A1 Dihydropyrazine derivatives as npy antagonists
12/28/2000WO2000078318A1 Medicinal composition for oral administration
12/28/2000WO2000078317A1 Integrin receptor antagonists
12/28/2000WO2000078316A1 Use of nitroxides in wound healing and in the prevention of photodamage
12/28/2000WO2000078315A1 Cyclohexenyl-ethyl-thiourea compounds and use
12/28/2000WO2000078313A1 Arylthiazolidinedione and aryloxazolidinedione derivatives
12/28/2000WO2000078312A1 Arylthiazolidinedione and aryloxazolidinedione derivatives
12/28/2000WO2000078311A1 Salts of aminoimidazole carboxamide useful in the prevention and treatment of liver diseases
12/28/2000WO2000078310A1 Indole compounds
12/28/2000WO2000078309A1 Indole compounds
12/28/2000WO2000078308A1 Antibiotic compound
12/28/2000WO2000078307A1 Orally administrable pharmaceutical preparation having therapeutic effect on gastrointestinal disorders comprising coated ranitidine, bismuth subcitrate and sucralfate
12/28/2000WO2000078306A1 Gold-containing chemotherapeutic agents
12/28/2000WO2000078305A1 Remedies for arthrosis deformans
12/28/2000WO2000078304A1 V.n. vassiliev's pharmaceutical composition for restoring the sympatho-adrenal system and method for estimating the efficiency thereof
12/28/2000WO2000078303A1 Non-malignant disease treatment with ras antagonists
12/28/2000WO2000078301A1 Anesthetic composition for intravenous injection comprising propofol
12/28/2000WO2000078299A2 Composition and method for preventing/reducing the severity of side effects of chemotherapy and/or radiation therapy
12/28/2000WO2000078298A2 Programming ovulation by administering estrogen such as estradiol
12/28/2000WO2000078297A2 Stable xylometazoline and oxymetazoline solution
12/28/2000WO2000078296A2 Tocotrienol and/or tocotrienol derivatives for the treatment or prophylaxis of glutamate- and/or calcium-induced disorders
12/28/2000WO2000078294A2 Oral administration form for administering a fixed tramadol and diclofenac combination
12/28/2000WO2000078293A1 New formulation
12/28/2000WO2000078292A1 Quickly disintegrating solid preparations
12/28/2000WO2000078291A1 Composition of paroxetine methanesulfonate
12/28/2000WO2000078290A2 Pharmaceutical composition comprising a salt of paroxetine
12/28/2000WO2000078289A1 Multilayered tablet for administration of a fixed combination of tramadol and diclofenac
12/28/2000WO2000078288A2 Novel process for paroxetine compositions
12/28/2000WO2000078286A1 Steroid solution aerosol products with enhanced chemical stability
12/28/2000WO2000078284A1 Stable benzimidazole formulation
12/28/2000WO2000078283A1 Stable l-ascorbic acid composition
12/28/2000WO2000078277A1 Micropigment mixture
12/28/2000WO2000078275A2 Antibacterial compositions
12/28/2000WO2000078272A2 Guerbet alcohols
12/28/2000WO2000078247A1 Oral pharmaceutical compositions containing taxanes and methods of treatment employing the same
12/28/2000WO2000078149A1 Anthelmintic compositions
12/28/2000WO2000078145A1 Macrophage scavenger receptor antagonists
12/28/2000WO2000063348A3 Pharmaceutical composition comprising pim-activated nkt cells, and therapeutic use thereof
12/28/2000WO2000061551A3 Pyrimidine-2-one derivatives as integrin receptor ligands
12/28/2000WO2000061123A3 Compound preparation made of vitamin d metabolites or vitamin d analogues and an oestrogenic component for treating osteoporosis
12/28/2000WO2000058460A3 Casb619 involved in colon cancers
12/28/2000WO2000056325A3 Ibuprofen solution
12/28/2000WO2000056301A3 Treatment of posttraumatic stress disorder, obsessive-compulsive disorder and related neuropsychiatric disorders
12/28/2000WO2000055162A3 Bicyclic heterocycles, pharmaceutical compositions containing these compounds, their use and processes for preparing them
12/28/2000WO2000054780A3 Corticosteroid formulation
12/28/2000WO2000054754A3 Composition comprising isoquercetin and ascorbic acid in a sustained release form
12/28/2000WO2000053149A3 Method and composition for administering a cyclooxygenase-2 inhibitor
12/28/2000WO2000052013A3 Thiazoloindolinone compounds
12/28/2000WO2000051593A3 Oral drug delivery system
12/28/2000WO2000049021A3 16-halogen-epothilone derivatives, method for producing them and their pharmaceutical use
12/28/2000WO2000047584A3 Epothilon derivatives, method for the production and the use thereof as pharmaceuticals
12/28/2000WO2000045851A3 Preparation for the prevention and/or treatment of a tissue change of mesenchymal origin
12/28/2000WO2000045845A3 Liposome composition and method for administration of a radiosensitizer
12/28/2000WO2000044379B1 Methods for restoring and/or enhancing accommodation in pseudo phakia
12/28/2000WO2000043495A3 33 human secreted proteins
12/28/2000WO2000043373A3 Kinase inhibitors
12/28/2000WO2000041526A3 Use of s-triazines for treating apicomplexan parasitic infections
12/28/2000WO2000037640A3 Compositions and methods for the treatment of tumor
12/28/2000WO2000034474A3 Growth factor homolog zvegf3
12/28/2000WO2000031093A3 Benzylglycosylamides as inhibitors of smooth muscle cell proliferation
12/28/2000WO1999052493A3 Compounds that inhibit the binding of integrins to their receptors
12/28/2000DE19958228A1 Paroxetinmethansulfonat enthaltendes Arzneimittel Paroxetine-containing medicines
12/28/2000DE19929715A1 New 11-beta-long chain substituted estratriene derivatives, are antiestrogens or tissue-selective partial estrogens useful e.g. for treating hormone-dependent cancer or osteoporosis
12/28/2000DE19929197A1 Transdermalsysteme zur Abgabe von 5-HT3-Rezeptor-Antagonisten und ihre Verwendung zur antiemitischen Behandlung Transdermal systems for the delivery of 5-HT3 receptor antagonists and their use for the treatment antiemitischen
12/28/2000DE19929076A1 New indanyl-substituted benzenesulfonamide derivatives, as potassium channel blockers useful as safe antiarrhythmic agents, e.g. for treating atrial fibrillation or flutter
12/28/2000DE19929065A1 Synergistic drug combination, especially for treating cardiovascular diseases associated with metabolic disorders, comprising bi- or tricyclic aza-heterocyclic MTP inhibitor and HMG-CoA reductase inhibitor
12/28/2000DE19929031A1 Synergistic drug combination, especially for treating cardiovascular diseases associated with metabolic disorders, comprising bi- or tricyclic aza-heterocyclic MTP inhibitor and lipid metabolism regulator or vitamin
12/28/2000DE19928495A1 Use of flavonoids for photostabilizing sorbate-containing compositions
12/28/2000DE19928342A1 New vector for tissue-specific expression, useful for treating tumors, contains gene for e.g. a cytotoxin under control of tissue-specific promoter and enhancer
12/28/2000DE19922662C1 Transdermales therapeutisches System (TTS) Tolterodin enthaltend Transdermal therapeutic system (TTS) containing tolterodine
12/28/2000DE19917705C1 Mittel zur Therapie von Hyperphosphatämie Means for therapy of hyperphosphatemia
12/28/2000DE19911680A1 New extracts and compounds from Ganoderma pfeifferi , useful e.g. as antibacterial and antiviral agents, preservatives, cosmetic, pharmaceutical and food additives and in fish farming, are protease inhibitors
12/28/2000CA2377698A1 Dihydropyrazine derivatives as npy antagonists
12/28/2000CA2377593A1 Remedies for skin ulcer
12/28/2000CA2377288A1 Macrophage scavenger receptor antagonists
12/28/2000CA2377246A1 Arylthiazolidinedione and aryloxazolidinedione derivatives
12/28/2000CA2376733A1 Aromatic and heterocyclic derivatives of phytosterols and/or phytostanols for use in treating or preventing cardiovascular disease
12/28/2000CA2376284A1 A method for the prophylaxis and/or treatment of medical disorders
12/28/2000CA2376155A1 Pharmaceutical composition for oral use
12/28/2000CA2376081A1 Cysteinyl protease inhibitors
12/28/2000CA2376077A1 Integrin receptor antagonists
12/28/2000CA2376007A1 Antibiotic compound
12/28/2000CA2375781A1 Compositions and methods for increasing cholesterol efflux and raising hdl using atp binding cassette transporter protein abci
12/28/2000CA2375771A1 Nucleic and proteinic acids corresponding to human gen abc1
12/28/2000CA2375508A1 Methods and products for manipulating uncoupling protein expression
12/28/2000CA2375493A1 Human transport proteins
12/28/2000CA2375396A1 High molecular weight primary aliphatic alcohols obtained from beeswax and pharmaceutical use thereof
12/28/2000CA2375358A1 Antibiotic agents
12/28/2000CA2375356A1 Substituted benzamide inhibitors of rhinovirus 3c protease
12/28/2000CA2375342A1 Phenetyl-thiourea compounds for treating hiv infections
12/28/2000CA2375312A1 Melamine derivatives as potent anti-cancer agents
12/28/2000CA2375282A1 Potassium channel openers
12/28/2000CA2375278A1 Thienopyrimidines
12/28/2000CA2375268A1 Indoloazepines as vasopressin receptor antagonists
12/28/2000CA2375265A1 Polymorphs of crystalline azo-bicyclo 2,2,2,oct-3-yl amine dihydrochloride and their pharmaceutical compositions
12/28/2000CA2375261A1 Thiophene-ethyl thiourea compounds and use in the treatment of hiv
12/28/2000CA2375211A1 Antiviral agents
12/28/2000CA2375182A1 5-cyano-2-aminopyrimidine derivatives
1 ... 6184 6185 6186 6187 6188 6189 6190 6191 6192 6193 6194 6195 6196 6197 6198 6199 6200 6201 6202 6203 6204 ... 7860